Fundraising Fox
🦊/Companies
Sign in

ImmuneOnco

1 known investors

Find your way into ImmuneOnco

ImmuneOnco Biopharmaceuticals is a Shanghai-founded clinical-stage biotech developing bispecific antibodies and Fc-fusion proteins for immuno-oncology and other diseases. It is publicly listed on the Hong Kong Stock Exchange.

Investors · 1

Curative VenturesDallas

In the news

Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M By Investing.cominvesting.com · Jan 2026BRIEF: ImmuneOnco to raise $45 million via share placement at 13% discount - Bamboo Works - China stock insights for global investorsthebambooworks.com · Oct 2025Instil Bio and ImmuneOnco Announce Joint Investor Breakfast in Chicago to Discuss Immuno-Oncology Developments | Nasdaqnasdaq.com · May 2025ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disordersprnewswire.com · Jul 2024China Digest: Bamboocloud bags $44m; Lilly Asia leads $25m funding in ImmuneOncodealstreetasia.com · Oct 2020

Frequently asked questions

What does ImmuneOnco do?
ImmuneOnco Biopharmaceuticals is a Shanghai-founded clinical-stage biotech developing bispecific antibodies and Fc-fusion proteins for immuno-oncology and other diseases. It is publicly listed on the Hong Kong Stock Exchange.
Who are ImmuneOnco's investors?
ImmuneOnco's investors include Curative Ventures.